Corporate Governance
Mayne Pharma’s Corporate Governance Policies
2022 Corporate Governance Statement (PDF)
Anti-Bribery & Anti-Corruption Policy (PDF)
Audit & Risk Committee Charter (PDF)
Board Charter (PDF)
Business Code of Conduct (PDF)
Diversity Policy (PDF)
Market Disclosure Policy (PDF)
Misconduct & Whistleblowing Policy (PDF)
Modern Slavery Report (PDF)
Nomination Committee Charter (PDF)
Remuneration and People Committee Charter (PDF)
Science, Technology and Medical Committee Charter (PDF)
Securities Trading Policy (PDF)
Supplier Code of Conduct (PDF)
Equal Opportunity 2021-2022 Report
In accordance with the requirements of the Workplace Gender Equality Act 2012, on 30 July 2022, Mayne Pharma lodged its annual report with the Workplace Gender Equality Agency.